Albumin human
- Generic Name
- Albumin human
- Brand Names
- Albuked, Albuminex, Alburex, Alburx, Albutein, Flexbumin, Hizentra, Human Albumin Grifols, Kedbumin, Octalbin, Plasbumin, Plasmanate
- Drug Type
- Biotech
- Chemical Formula
- -
- CAS Number
- 9048-46-8
- Unique Ingredient Identifier
- ZIF514RVZR
- Background
Human serum albumin is the primary protein present in human blood plasma. The main function of albumin is to maintain the oncotic pressure of blood . It binds to water, cations (such as Ca2+, Na+ and K+), fatty acids, hormones, bilirubin, thyroxine (T4) and pharmaceuticals (including barbiturates). Albumin represents approximately 50% of the total protein co...
- Indication
Albuminex solution is indicated for adults and children for hypovolemia, ascites, hypoalbuminemia including from burns, acute nephrosis, acute respiratory distress syndrome and cardipulmonary bypass .
- Associated Conditions
- Acute Pyelonephritis(APN), Burns, Hemolytic Disease of the Newborn, Hypoalbuminemia, Hypoproteinemia, Hypovolaemia, Shock, Hypovolemic, Acute fulminant liver failure, Central volume depletion, Post-operative albumin loss
- Associated Therapies
- -
Agitated Saline, Albumin, or Propofol-albumin Mixture for Enhanced Contrast in TEE Examinations
- Conditions
- Interventions
- First Posted Date
- 2015-11-24
- Last Posted Date
- 2019-09-25
- Lead Sponsor
- University of California, San Diego
- Target Recruit Count
- 17
- Registration Number
- NCT02613052
- Locations
- 🇺🇸
UC San Diego Sulpizio Cardiovascular Center, La Jolla, California, United States
Albumin Infusion Effects in Mortality in Patients With Cirrhosis and Hepatic Encephalopathy
- First Posted Date
- 2015-03-27
- Last Posted Date
- 2017-12-28
- Target Recruit Count
- 128
- Registration Number
- NCT02401490
- Locations
- 🇪🇸
Corporació Sanitària Parc Taulí, Sabadell, Barcelona, Spain
🇪🇸Hospital Universitari Vall d'Hebron, Barcelona, Spain
🇪🇸Hospital Clínic de Barcelona, Barcelona, Spain
The Impact of IVIG Treatment on Critical Illness Polyneuropathy and/or Myopathy in Patients With MOF and SIRS/Sepsis
- Conditions
- Interventions
- First Posted Date
- 2013-06-04
- Last Posted Date
- 2013-06-04
- Lead Sponsor
- Medical University of Vienna
- Target Recruit Count
- 38
- Registration Number
- NCT01867645
- Locations
- 🇦🇹
Medical University of Vienna, Vienna, Austria
The Therapeutic Role of Intravenous Albumin Administration for Peptic Ulcer Bleeding Patients With Hypoalbuminemia
- Conditions
- Interventions
- First Posted Date
- 2013-04-02
- Last Posted Date
- 2019-08-29
- Lead Sponsor
- National Cheng-Kung University Hospital
- Target Recruit Count
- 91
- Registration Number
- NCT01822600
- Locations
- 🇨🇳
National Cheng Kung University Hospital, Tainan, Taiwan
Treatment of Subarachnoid Hemorrhage With Human Albumin
- First Posted Date
- 2012-12-11
- Last Posted Date
- 2012-12-11
- Lead Sponsor
- Baylor College of Medicine
- Target Recruit Count
- 47
- Registration Number
- NCT01747408
- Locations
- 🇺🇸
Baylor College of Medicine, Houston, Texas, United States
Fluid Resuscitation in Patients Suffering From Burns Injury
- First Posted Date
- 2012-09-21
- Last Posted Date
- 2014-06-26
- Lead Sponsor
- Fresenius Kabi
- Target Recruit Count
- 11
- Registration Number
- NCT01689506
- Locations
- 🇬🇧
University Hospitals Birmingham NHS Foundation Trust, Queen Elizabeth Hospital, Queen Elizabeth Medical Centre, Birmingham, United Kingdom
VolulyteTM in Cardiac Surgery
- First Posted Date
- 2012-03-14
- Last Posted Date
- 2014-06-26
- Lead Sponsor
- Fresenius Kabi
- Target Recruit Count
- 133
- Registration Number
- NCT01553617
- Locations
- 🇨🇦
Toronto General Hospital, Toronto, Ontario, Canada
🇨🇦St. Michael's Hospital, Toronto, Ontario, Canada
🇨🇦London Health Sciences Centre, London, Ontario, Canada
Albumin Administration in Cirrhotic Patients With Bacterial Infection and a Systemic Inflammatory Response Syndrome Unrelated to Spontaneous Bacterial Peritonitis
- First Posted Date
- 2011-05-25
- Last Posted Date
- 2014-05-13
- Lead Sponsor
- Centre Hospitalier Universitaire de Besancon
- Target Recruit Count
- 193
- Registration Number
- NCT01359813
- Locations
- 🇫🇷
Hôpital Jean Verdier, Bondy, France
🇫🇷Hôpital Antoine Béclère, Clamart, France
🇫🇷CHIC, Créteil, France
Trial of the Efficacy of Intravenous Immunoglobulin for Treating Women With Unexplained Secondary Recurrent Miscarriage
- Conditions
- Interventions
- First Posted Date
- 2008-07-25
- Last Posted Date
- 2014-11-06
- Lead Sponsor
- Rigshospitalet, Denmark
- Target Recruit Count
- 82
- Registration Number
- NCT00722475
- Locations
- 🇩🇰
Fertility Clinic 4071, Rigshospitalet, Copenhagen, Denmark
High Dose Hyperoncotic Serum Albumin for the Treatment of the Acute Phase of Severe Head Injury
- Conditions
- First Posted Date
- 2005-09-09
- Last Posted Date
- 2005-12-01
- Lead Sponsor
- University Hospital, Angers
- Target Recruit Count
- 40
- Registration Number
- NCT00152685
- Locations
- 🇫🇷
Neurosurgical intensive care. CHU de Nancy, Nancy, France
🇫🇷Surgical intensive care. CHU, Angers, Cedex 9, France
🇫🇷Neurosurgical intensive care. CHU Le Kremlin Bicêtre, Le Kremlin Bicêtre, France
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.